Acyclovir – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 08 Mar 2023 09:49:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Acyclovir – VJRegenMed https://mirror.vjregenmed.com 32 32 Infection prevention in patients receiving CAR T-cells https://mirror.vjregenmed.com/video/hfwzgaat308-infection-prevention-in-patients-receiving-car-t-cells/ Fri, 26 Feb 2021 14:08:26 +0000 http://13.40.107.223/video/hfwzgaat308-infection-prevention-in-patients-receiving-car-t-cells/ Joshua Hill, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, explores the strategies and recommendations for infection prophylaxis and monitoring in CAR-T patients. Dr Hill discusses antibacterial, antiviral, and antifungal prophylaxis. IV IG is reserved for patients with very low IgG levels and recurrent or severe bacterial infections primarily. Additionally, vaccination strategies post CAR T-cell therapy are debated, including COVID-19 vaccination. This interview took place during the 3rd European CAR T-cell Meeting.

]]>